Undertaking for non - applicability of reg 32 of sebi (lodr) reg 2015

J O H N S O N PHARMACARE LIMITED CIN: L51100GJ1994PLC022388 Registered & Corp. Office Address - I-460, Fourth Floor, Titanium City Centre Mall, Near Sachin Tower, Anand Nagar Road, Satellite, Ahmedabad-380015 Email id: johnsonpharmacare1994@gmail.com sunandshineworldwideltd@gmail.com Date: 13.08.2026 The Department of Corporate ServiÎ BSE Limited PhirozeJeejeebhoy Towers, Dalal Street, Mumbai – 400001. SCRIP CODE: 532154 (JOHNSON PHARMACARE LTD) EQ - ISIN - INE560F01022 Subject: Undertaking for Non- Applicability of Regulation 32 of SEBI (LODR) Regulations, 2015 for the quarter ended on June 30th, 2026. Dear Sir/Madam, As per Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the listed entity shall submit to the stock exchange the following statement(s) for quarter ended on June 30th, 2026 for public issue, rights issue, preferential issue etc. – (a) Indicating deviations, if any, in the use of proceeds from the objects stated in the offer document or explanatory statement to the notice for the general meeting, as applicable; (b) Indicating category wise variation (capital expenditure, sales and marketing, working capital etc.) between projected utilization of funds made by it in its offer document or explanatory statement to the notice for the general meeting, as applicable and the actual utilization of funds. In view of the aforesaid, I, the undersigned, Mr. NAND KISHOR RAY, Director of JOHNSON PHARMACARE LTD hereby certify that Compliances of Regulation 32 of SEBI (LODR) regulations, 2015 is not applicable to the company as the company has not issued any share by way of public issue, right issue, preferential issue etc. for the quarter ended on June 30th, 2026. You are requested to take the above on your records and acknowledge the same. For and on behalf of Board of Directors JOHNSON PHARMACARE LIMITED Nand Kishor Ray Additional Director DIN: 11626638 Date: 13-08-2026 Place: Gujrat